Diligence memo · auto-generated · as of July 2, 2026
Fera Diagnostics & Biologicals Corp.
Fera Diagnostics & Biologicals Corp. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Fera Diagnostics & Biologicals Corp. operates in Medical Devices, based in ITHACA.
Sub-sector tags: medical-devices.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Fera Diagnostics & Biologicals Corp. has raised $1.5M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $1.5M on 2021-01-27.
Most recent recorded round closed around 2021-01-27.
Valuation (modeled)modeled
Provath models Fera Diagnostics & Biologicals Corp. at approximately $34M (range $1.2M–$229M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.81× the median modeled value of Seed Medical Devices companies in 2019–2021 (23 peers) — value vs value, same stage and era. Within the normal band (81% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 5.4 yr ago; this sector typically re-raises about every 16 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 48% of Medical Devices peers (233 compared).
Modeled value ranks above 70% of those peers.
Closest niche peers: Gradian Diagnostics Inc, Regent Surgical Health Intermediate Holdings, Inc., Caliber Imaging & Diagnostics, Inc., Dxterity Diagnostics Inc, Sure Count Surgical, LLC.
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.